<SEC-DOCUMENT>0001213900-25-042398.txt : 20250513
<SEC-HEADER>0001213900-25-042398.hdr.sgml : 20250513
<ACCEPTANCE-DATETIME>20250513113356
ACCESSION NUMBER:		0001213900-25-042398
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250513
FILED AS OF DATE:		20250513
DATE AS OF CHANGE:		20250513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moolec Science SA
		CENTRAL INDEX KEY:			0001937737
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			N4
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41586
		FILM NUMBER:		25938196

	BUSINESS ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
		BUSINESS PHONE:		352 26 49 65 65

	MAIL ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0241796-6k_moolec.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Rules&nbsp;13a-16 or 15d-16 under</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the month of May 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File Number: 001-41586</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>MOOLEC SCIENCE SA </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of Registrant as Specified in Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>17, Boulevard F. W. Raiffeisen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>L-2411 Luxembourg,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Grand Duchy of Luxembourg</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form&nbsp;20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form&nbsp;40-F&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT LIST</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><B>Exhibit No.</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"><B>Description</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea024179601ex99-1_moolec.htm">Press release of Moolec Science SA dated May 12, 2025.</A></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MOOLEC SCIENCE SA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: May 13, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jos&eacute; L&oacute;pez Lecube</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jos&eacute; L&oacute;pez Lecube</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea024179601ex99-1_moolec.htm
<DESCRIPTION>PRESS RELEASE OF MOOLEC SCIENCE SA DATED MAY 12, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Moolec Science Announces
Effectiveness of Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Luxembourg. May 12,
2025.</B> Moolec Science SA (NASDAQ: MLEC; &ldquo;The Company&rdquo;; &ldquo;Moolec&rdquo;), a science-based food ingredient company focused
on producing animal proteins and nutritional oils in plants, today announced that, in accordance with the terms of the resolutions passed
at the extraordinary general meeting of the shareholders of the Company, held on April 22, 2025, and resolutions adopted by the board
of directors of the Company on April 22, 2025, which resolved to approve a consolidation ratio of one-for-ten (1-for-10) every ten ordinary
shares, par value U$0.01, of the Company (the &ldquo;Shares&rdquo;) then issued and outstanding will automatically, and without any action
any holder thereof, be consolidated into one validly issued and non-assessable Share without any change of the par value per share (the
&ldquo;Reverse Stock Split&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company anticipates
that the Reverse Stock Split will take effect May 14, 2025, 8:30 AM Eastern Time (the &ldquo;Effective Time&rdquo;) and will be reflected
in the market at the start of trading, on a split-adjusted basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Shares will continue
to trade on the NASDAQ under the symbol &ldquo;MLEC&rdquo; under a new CUSIP code, which is L64875 120. The Company&rsquo;s publicly traded
warrants will continue to be traded under the symbol &ldquo;MLECW&rdquo; under the same CUSIP code, which is L64875 112.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As a result of the Reverse
Stock Split the number of issued and outstanding Shares will be reduced from approximately 40 million Shares to approximately 4 million
Shares. The Reverse Stock Split does not otherwise affect the Company&rsquo;s business or operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Following the Effective
Time, the number of Shares issuable upon exercise or vesting of outstanding equity awards, options and warrants, and the per share exercise
or purchase price related thereto, if any, will be equitably adjusted in accordance with the terms of the 2024 Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Registered shareholders
are not required to take any action to receive Shares in connection with the Reverse Stock Split. Shareholders owning shares through an
account at a brokerage firm, bank, dealer, custodian or other similar organization acting as nominee will have their positions automatically
adjusted to reflect the Reverse Stock Split, subject to such broker&rsquo;s particular processes, and likewise will not be required to
take any action in connection with the Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>About Moolec Science
SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec is a science-based ingredient company leader
in the use of Molecular Farming technology for the food and dietary supplementation markets. The Company&rsquo;s mission is to create
unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the world produces animal
proteins for the good of the planet. Moolec&rsquo;s technological approach aims to have the cost structure of plant-based solutions with
the nutrition and functionality of animal-based ones. The Company&rsquo;s technology has been under development for more than a decade
and is known for pioneering the production of a bovine protein in a crop for the food industry. Moolec&rsquo;s product portfolio and pipeline
leverages the agronomic efficiency of broadly used target crops, like soybean, pea, and safflower to produce oils and proteins. The Company
has an industrial and commercial R&amp;D capability to complement their Molecular Farming technology and secures a growing international
patent portfolio (25+, both granted and pending) for its technology. Moolec is run by a diverse team of Ph.Ds and Food Insiders, and operates
in the United States, Europe, and South America. For more information, visit moolecscience.com and ir.moolecscience.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements.&rdquo; Forward-looking statements may be identified by the use of words such as &ldquo;forecast,&rdquo; &ldquo;intend,&rdquo;
&ldquo;seek,&rdquo; &ldquo;target,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;outlook,&rdquo; and &ldquo;project&rdquo; and other similar expressions that predict or indicate future events
or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues,
and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current
expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis
for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of
facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will
prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual
results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility
that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec&rsquo;s
business and other risks and uncertainties, including those included under the header &ldquo;Risk Factors&rdquo; in Moolec&rsquo;s Annual
Report on Form 20-F filed with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), as well as Moolec&rsquo;s other filings
with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual
results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or
revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under
applicable securities laws. Accordingly, you should not put undue reliance on these statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Moolec Science&rsquo;s Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Press &amp; Media inquiries: comms@moolecscience.com</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Investor Relations inquiries: ir@moolecscience.com</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !I )T# 2(  A$! Q$!_\0
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MYD4-'SB*-68?1<#)]VQVKS;XE^-=)U/PAX*BT74M]_I\:O)Y8(:!U1 ,^AW
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7Z4!0#D#FEHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
